tiprankstipranks
Applied Therapeutics downgraded to Market Perform from Outperform at William Blair
PremiumThe FlyApplied Therapeutics downgraded to Market Perform from Outperform at William Blair
30d ago
Applied Therapeutics price target lowered to $1.50 from $4 at RBC Capital
Premium
The Fly
Applied Therapeutics price target lowered to $1.50 from $4 at RBC Capital
1M ago
Applied Therapeutics Faces Leadership Changes and Regulatory Hurdles
Premium
Company Announcements
Applied Therapeutics Faces Leadership Changes and Regulatory Hurdles
1M ago
Applied Therapeutics downgraded to Neutral from Buy at UBS
PremiumThe FlyApplied Therapeutics downgraded to Neutral from Buy at UBS
2M ago
Applied Therapeutics price target lowered to $5 from $14 at Baird
Premium
The Fly
Applied Therapeutics price target lowered to $5 from $14 at Baird
2M ago
Applied Therapeutics (APLT) Stock Plunges 75% as FDA Rules Against Genetic Drug
Premium
Market News
Applied Therapeutics (APLT) Stock Plunges 75% as FDA Rules Against Genetic Drug
2M ago
Voyager rises after upgrade, Applied plunges after CRL: Morning Movers
PremiumThe FlyVoyager rises after upgrade, Applied plunges after CRL: Morning Movers
2M ago
Applied Therapeutics CRL a ‘major setback,’ says William Blair
Premium
The Fly
Applied Therapeutics CRL a ‘major setback,’ says William Blair
2M ago
Applied Therapeutics downgraded to Sector Perform from Outperform at RBC
Premium
The Fly
Applied Therapeutics downgraded to Sector Perform from Outperform at RBC
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100